FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OSPHENA (ospemifene) filed by Duchesnay USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia Due to Vulvar and Vaginal Atrophy Resulting From Menopause
• Vulvar and Vaginal Atrophy

Drugs mentioned

• Osphena (ospemifene)

Snippet

SUPPL AP for OSPHENA (OSPEMIFENE)